StockClub

KYMR

KYMRKymera Therapeutics, Inc.$ --
Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc.

KYMR

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
3M USD
YoY -61.3%
Operating Income
-98M USD
YoY -21.2%
Net Income
-87M USD
YoY -23.0%
EPS
-0.98$
YoY -11.4%

Revenue

$39.2M
FY2024 Q1$10.3M
$10.3M
Q1
FY2024 Q2$35.9M
$35.9M
Q2
FY2024 Q3$39.7M
$39.7M
Q3
FY2024 Q4$47.1M
$47.1M
Q4
FY2025 Q1$22.1M
$22.1M
Q1
FY2025 Q2$33.6M
$33.6M
Q2
FY2025 Q3$36.3M
$36.3M
Q3
FY2025 Q4$39.2M
$39.2M
Q4
Actual
$-7.9M (-16.7%)

Net Income

$-311.4M
FY2024 Q1$-48.6M
$-48.6M
Q1
FY2024 Q2$-90.6M
$-90.6M
Q2
FY2024 Q3$-153.1M
$-153.1M
Q3
FY2024 Q4$-223.9M
$-223.9M
Q4
FY2025 Q1$-65.6M
$-65.6M
Q1
FY2025 Q2$-142.2M
$-142.2M
Q2
FY2025 Q3$-224.4M
$-224.4M
Q3
FY2025 Q4$-311.4M
$-311.4M
Q4
Actual
$-87.5M (-39.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$34M
Est:$42M
FY2020MISS
$34M
FY2021MISS
Actual:$72.8M
Est:$83.7M
FY2021MISS
$72.8M
FY2022MISS
Actual:$46.8M
Est:$50.2M
FY2022MISS
$46.8M
FY2023MISS
Actual:$78.6M
Est:$88.5M
FY2023MISS
$78.6M
FY2024MISS
Actual:$47.1M
Est:$53.9M
FY2024MISS
$47.1M
FY2025MISS
Actual:$39.2M
Est:$53.9M
FY2025MISS
$39.2M

Analyst Estimates